Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model
Hiroko Otake,Ko Kobayashi,Reita Kadowaki,Taiyo Kosaka,Mizuki Itahashi,Masanobu Tsubaki,Masaru Matsuda,Norio Iwakiri,Eiji Harata,Noriaki Nagai
DOI: https://doi.org/10.2147/dddt.s469445
IF: 4.3188
2024-09-27
Drug Design Development and Therapy
Abstract:Hiroko Otake, 1, &ast Ko Kobayashi, 2, &ast Reita Kadowaki, 1 Taiyo Kosaka, 1 Mizuki Itahashi, 1 Masanobu Tsubaki, 1 Masaru Matsuda, 2 Norio Iwakiri, 2 Eiji Harata, 2 Noriaki Nagai 1 1 Faculty of Pharmacy, Kindai University, Osaka, Japan; 2 Life Science Division, NOF CORPORATION, Kanagawa, Japan &astThese authors contributed equally to this work Correspondence: Noriaki Nagai, Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, Japan, Tel +81 6 4307 3638, Fax +81 6 6730 1394, Email Purpose: We aimed to prepare a β-cyclodextrin (β-CD) polymer using radical polymerization with co-monomers, 6-deoxy-6-(2-methacryloyloxyethylsuccinamide)-β-cyclodextrin (CD-MSAm) and N,N,N-trimethyl-N-(2-hydroxy-3-metacryloyloxopropyl)-ammonium chloride (QA) to design cyclodextrins suitable for use in ophthalmology. In addition, we evaluated their solubility and inclusion properties with rebamipide (REB), a poorly soluble drug, and investigated the usefulness of the β-CD polymer and REB (REB@CDQA) combination in treating dry eye. Methods: The β-CD polymer (CD-MSAm-co-QA, CDQA) based on CD-MSAm/QA was prepared via radical polymerization, and the usefulness of REB@CDQA in treating dry eye was evaluated using a rabbit treated with N-acetylcysteine (dry eye model). Results: The solubility of the CDQA powder was higher than that of the β-CD powder, and 80 nm colloids were observed in the CDQA solution. No corneal toxicity was observed in human corneal epithelial cells or rat corneas treated with 0.2% CDQA solution. The levels of REB dissolved in the CDQA solution were higher than those of the β-CD solution. Moreover, the application of the CDQA solution enhanced REB retention in the cornea and attenuated the transcorneal penetration of REB. In addition, instillation of REB@CDQA enhanced the volume of the lacrimal fluid and normalized the reduced mucin levels in the dry eye model. The extent of tear film breakup was attenuated by REB@CDQA instillation. Conclusion: The CDQA solution enhanced the solubility of REB, and the combination of CDQA and REB enhanced the drug content in the corneal tissue. Moreover, the therapeutic effect on dry eye was higher than that of REB suspensions without CDQA. Keywords: β-cyclodextrin, polymer, cationic group, rebamipide, dry eye Graphical Tear film instability is caused by a disturbance in ocular surface mucin levels, resulting in dry eye disease. Although vision may not be affected adversely, dry eye disease causes various problems, including photophobia, dryness, and tearing, leading to a measurable adverse impact on daily life. 1,2 If left untreated, dry eye disease does not heal naturally, and its symptoms persist. However, treatments for improving the signs and symptoms may not cure the condition completely. 1,2 The putative pathogenetic mechanisms of dry eye disease include the formation of a hyperosmolar tear film and inflammation of the lacrimal gland, resulting in impaired stabilization of the aqueous layer due to a reduction in mucin levels on the ocular surface. 3 Therefore, enhancing tear rear-film stability via improvement of mucin levels is important for managing dry eye disease. Clinically, mucin secretagogues, corticosteroids, anti-inflammatory medications, autologous serum eye drops, artificial tear products, and punctal plugs are used for treating dry eye disease. Rebamipide (REB) is a quinolinone derivative with mucin secretagog activity, and the biological effects include prevention of inflammation, wound healing, and cytoprotection in various tissues. 4–7 With respect to dry eye disease, REB increases mucin production in corneal epithelial and conjunctival goblet cells, 8–10 and promotes the healing of conjunctival and corneal injuries by enhancing the secretion of both secreted-type and membrane-associated mucins. 11 Thus, REB possesses multiple pharmacological properties, such as anti-inflammatory activity, 12 and the ability to promote mucin secretion, increase the number of goblet cells, 10,11 and restore the barrier function of the corneal epithelium. 4,5 However, it is used as a suspension due to its poor solubility, and efforts to improve drug retention and solubility in corneal tissue are presently required. Cyclodextrins (CD) are cyclic oligosaccharides D-glucopyranose molecules with hydrophilic surface and hydrophobic cavity. CDs can accommodate guest molecules via the formation of inclusion complexes because of the presence of a lipophilic domain. 13 Three types of CDs were cl -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal